These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1019148)

  • 21. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo.
    Kalderon B; Mayorek N; Ben-Yaacov L; Bar-Tana J
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E795-803. PubMed ID: 12488241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential hypolipidemic agents. 3. Heterocyclic compounds affecting free fatty acid mobilization in vivo.
    Carlson LA; Hedbom C; Helgstrand E; Sjöberg B; Stjernström NE
    Acta Pharm Suec; 1972 Sep; 9(4):289-304. PubMed ID: 4655344
    [No Abstract]   [Full Text] [Related]  

  • 23. Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil.
    Fitzgerald JE; Sanyer JL; Schardein JL; Lake RS; McGuire EJ; de la Iglesia FA
    J Natl Cancer Inst; 1981 Nov; 67(5):1105-16. PubMed ID: 7029098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New lipid-lowering drug now on the market.
    JAMA; 1982 Mar; 247(11):1540. PubMed ID: 6950126
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies on the mechanism of nicotine-induced lipolysis in man].
    Ratzmann KP; Meyer LW; Riemer D
    Z Gesamte Inn Med; 1974 May; 29(10):410-3. PubMed ID: 4849795
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
    Gastaldelli A; Casolaro A; Ciociaro D; Frascerra S; Nannipieri M; Buzzigoli E; Ferrannini E
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E225-30. PubMed ID: 19417125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic effects of substances influencing arrhythmias].
    Siedek H; Hammerl H; Kräntzl C; Pichler O; Studlar M
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():227-31. PubMed ID: 5380594
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of hexobendine on the alloxan diabetic animal].
    Kraupp O; Niessner H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):34-5. PubMed ID: 4231847
    [No Abstract]   [Full Text] [Related]  

  • 29. Gemfibrozil--a new lipid lowering agent.
    Nash DT
    J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemfibrozil--a new lipid lowering agent.
    Hodges RM
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):1-2. PubMed ID: 798192
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of antidiabetics on the fat metabolism of alloxan-diabetic rats].
    Reissert K; Rudas B
    Arzneimittelforschung; 1969 Jun; 19(6):1019-21. PubMed ID: 5820029
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of repeated doses of phenyl-isopropyl-adenosine on lipid and carbohydrate metabolism in healthy fasting test subjects].
    Schaumann E; Schlierf G; Pfleiderer T; Weber E
    Arzneimittelforschung; 1972 Mar; 22(3):593-6. PubMed ID: 5067937
    [No Abstract]   [Full Text] [Related]  

  • 33. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 34. [Metabolic activity of theophylline].
    Nahas GG
    Therapie; 1969; 24(5):925-36. PubMed ID: 5364211
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thermogenesis in cold-exposed white mice under the influence of nicotinic acid].
    Estler CJ; Ammon HP; Lang B
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):225-6. PubMed ID: 4242379
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antilipolytic effect of propranolol in the dog.
    Grassi AO; De Lew MN; Cingolani HE
    Life Sci; 1969 Nov; 8(21):1239-45. PubMed ID: 5358660
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of the lipolysis blocker 5-methylpyrazol-3-carbonic acid (MPC) on changes in carbohydrate and lipid metabolism induced by muscle work in insulin-requiring diabetics].
    Schulz B; Michaelis D; Neumann I; Schäfer H; Wulfert P
    Z Gesamte Inn Med; 1973 Jun; 28(12):345-50. PubMed ID: 4729261
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of cyclonicate, a new hypolipemic drug, on lipolysis in vitro.
    Tessari F; Caparrotta L; Gaion RM; Fassina G
    Farmaco Sci; 1981 Dec; 36(12):1029-36. PubMed ID: 6274681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of 2-phenyl-3-methyl-3-hydroxypentanoic and 2,3-diphenyl-3-hydroxypentanoic acids on the lipolytic activity of rat adipose tissue].
    Klimov AN; Vasil'eva LE; Petrova LA; Poliakova ED; Riazanova TV
    Vopr Med Khim; 1975; 21(2):189-92. PubMed ID: 1138508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.